Cytek Biosciences

CTKB · NASDAQ

$5.34+$0.09 (+1.71%)TodayMarket closed · Oct 20, 7:51 PM ET

Prev close $5.25

CTKB analyst rating

BuyConsensus of 4 analysts over the last 12 months. 75% rate it a buy.

Strong buy0
Buy3
Hold1
Underperform0
Sell0

12-month price target · 6 analysts

Average $5.67 (+6.2% upside)

Low: $4.80
Now: $5.34
High: $7.88

Upgrades and downgrades

The latest rating actions, newest first

CTKB analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Stephens & Co.	May 13, 2026	Maintains	Overweight	$5.50 → $4.75	51%
Morgan Stanley	May 12, 2026	Maintains	Equal-Weight	$6.00 → $5.50	48%
TD Cowen	Jan 8, 2026	Maintains	Buy	$4.00 → $5.00	68%
Piper Sandler	Nov 11, 2025	Maintains	Overweight	$8.00 → $7.50	58%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.